ENSC ▼ -4.1% - Ensysce Biosciences, Inc. $ENSC - Ensysce Biosciences' Professor Richard Langford Selected to Speak at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs Ensysce Biosciences fell 4.1% today despite the company securing a speaking slot for Professor Richard Langford at an FDA public hearing on psychedelic therapeutics, suggesting investors may have been disappointed by the lack of commercial progress or clinical advancement announcements alongside the speaking opportunity. 14-SEP-2026 08:00 AM ET